Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 645

1.

Operational Performance of the Onchocerca volvulus "OEPA" Ov16 ELISA Serological Assay in Mapping, Guiding Decisions to Stop Mass Drug Administration, and Posttreatment Surveillance Surveys.

Richards FO, Katabarwa M, Bekele F, Tadesse Z, Mohammed A, Sauerbrey M, Dominguez-Vazquez A, Rodriguez-Perez MA, Fernández-Santos NA, Rizzo N, Schuler Martínez HR, Lovato Silva R, Morales Monroy Z, Habomugisha P, Oguttu DW, Zarroug IMA, Aziz NA, Unnasch TR.

Am J Trop Med Hyg. 2018 Sep;99(3):749-752. doi: 10.4269/ajtmh.18-0341. Epub 2018 Jul 12.

PMID:
30014821
2.

Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.

Griswold E, Eigege A, Ityonzughul C, Emukah E, Miri ES, Anagbogu I, Saka YA, Kadiri S, Adelamo S, Ugbadamu P, Ikogho C, Richards FO.

Am J Trop Med Hyg. 2018 Aug;99(2):396-403. doi: 10.4269/ajtmh.17-1004. Epub 2018 Jun 21.

PMID:
29943709
3.

The ATR Inhibitor AZD6738 Synergizes with Gemcitabine In Vitro and In Vivo to Induce Pancreatic Ductal Adenocarcinoma Regression.

Wallez Y, Dunlop CR, Johnson TI, Koh SB, Fornari C, Yates JWT, Bernaldo de Quirós Fernández S, Lau A, Richards FM, Jodrell DI.

Mol Cancer Ther. 2018 Aug;17(8):1670-1682. doi: 10.1158/1535-7163.MCT-18-0010. Epub 2018 Jun 11.

PMID:
29891488
4.

In Southern Nigeria Loa loa Blood Microfilaria Density is Very Low Even in Areas with High Prevalence of Loiasis: Results of a Survey Using the New LoaScope Technology.

Emukah E, Rakers LJ, Kahansim B, Miri ES, Nwoke BEB, Griswold E, Saka Y, Anagbogu I, Davies E, Ityonzughul C, D'Ambrosio M, Bakalar M, Fletcher DA, Nutman T, Kamgno J, Richards FO.

Am J Trop Med Hyg. 2018 Jul;99(1):116-123. doi: 10.4269/ajtmh.18-0163. Epub 2018 May 10.

PMID:
29761763
5.

Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine.

Koh SB, Wallez Y, Dunlop CR, Bernaldo de Quirós Fernández S, Bapiro TE, Richards FM, Jodrell DI.

Cancer Res. 2018 Jun 1;78(11):3054-3066. doi: 10.1158/0008-5472.CAN-17-3932. Epub 2018 May 7.

PMID:
29735549
6.

The role of the NGDO Coordination Group for the Elimination of Onchocerciasis.

Elhassan E, Zhang Y, Bush S, Molyneux D, Kollmann MKH, Sodahlon Y, Richards F.

Int Health. 2018 Mar 1;10(suppl_1):i97-i101. doi: 10.1093/inthealth/ihx050.

PMID:
29471339
7.

The role of national committees in eliminating onchocerciasis.

Griswold E, Unnasch T, Eberhard M, Nwoke BEB, Morales Z, Muheki Tukahebwa E, Kebede B, Anagbogu I, Katabarwa M, Habomugisha P, Tadesse Z, Miri ES, Evans D, Cohn D, Elhassan E, Richards F.

Int Health. 2018 Mar 1;10(suppl_1):i60-i70. doi: 10.1093/inthealth/ihx048.

PMID:
29471337
8.

After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight.

Katabarwa MN, Lakwo T, Habomugisha P, Unnasch TR, Garms R, Hudson-Davis L, Byamukama E, Khainza A, Ngorok J, Tukahebwa E, Richards FO.

Int Health. 2018 Mar 1;10(suppl_1):i79-i88. doi: 10.1093/inthealth/ihx044.

PMID:
29471335
9.

Progress toward elimination of onchocerciasis in the Americas.

Sauerbrey M, Rakers LJ, Richards FO.

Int Health. 2018 Mar 1;10(suppl_1):i71-i78. doi: 10.1093/inthealth/ihx039.

PMID:
29471334
10.

Mass Administration of Ivermectin in Areas Where Loa loa Is Endemic.

Richards FO Jr.

N Engl J Med. 2017 Nov 23;377(21):2088-2090. doi: 10.1056/NEJMe1712713. Epub 2017 Nov 8. No abstract available.

11.

Criteria to Stop Mass Drug Administration for Lymphatic Filariasis Have Been Achieved Throughout Plateau and Nasarawa States, Nigeria.

Eigege A, Evans DS, Noland GS, Davies E, Umaru J, Adelamo SE, Mancha B, King JD, Miri ES, Okoeguale B, Griswold EP, Richards FO Jr.

Am J Trop Med Hyg. 2017 Sep;97(3):677-680. doi: 10.4269/ajtmh.16-0843. Epub 2017 Jul 27.

12.

Modelling of the cancer cell cycle as a tool for rational drug development: A systems pharmacology approach to cyclotherapy.

Jackson RC, Di Veroli GY, Koh SB, Goldlust I, Richards FM, Jodrell DI.

PLoS Comput Biol. 2017 May 3;13(5):e1005529. doi: 10.1371/journal.pcbi.1005529. eCollection 2017 May.

13.
14.

Skin snips have no role in programmatic evaluations for onchocerciasis elimination: a reply to Bottomley et al.

Eberhard ML, Cupp EW, Katholi CR, Richards FO, Unnasch TR.

Parasit Vectors. 2017 Mar 23;10(1):154. doi: 10.1186/s13071-017-2090-z.

15.

Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.

Xu R, Richards FM.

Comb Chem High Throughput Screen. 2017;20(5):451-457. doi: 10.2174/1386207320666170202093538. Review.

PMID:
28155598
16.

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer.

Hessmann E, Patzak MS, Klein L, Chen N, Kari V, Ramu I, Bapiro TE, Frese KK, Gopinathan A, Richards FM, Jodrell DI, Verbeke C, Li X, Heuchel R, Löhr JM, Johnsen SA, Gress TM, Ellenrieder V, Neesse A.

Gut. 2018 Mar;67(3):497-507. doi: 10.1136/gutjnl-2016-311954. Epub 2017 Jan 10.

17.

Interruption of the transmission of Onchocerca volvulus in the Kashoya-Kitomi focus, western Uganda by long-term ivermectin treatment and elimination of the vector Simulium neavei by larviciding.

Lakwo T, Garms R, Wamani J, Tukahebwa EM, Byamukama E, Onapa AW, Tukesiga E, Katamanywa J, Begumisa S, Habomugisha P, Oguttu D, Byamukama E, Richards F, Unnasch TR, Katabarwa M.

Acta Trop. 2017 Mar;167:128-136. doi: 10.1016/j.actatropica.2016.12.029. Epub 2016 Dec 26.

PMID:
28034767
18.

A quantitative FastFUCCI assay defines cell cycle dynamics at a single-cell level.

Koh SB, Mascalchi P, Rodriguez E, Lin Y, Jodrell DI, Richards FM, Lyons SK.

J Cell Sci. 2017 Jan 15;130(2):512-520. doi: 10.1242/jcs.195164. Epub 2016 Nov 25.

19.

The First Confirmed Elimination of an Onchocerciasis Focus in Africa: Abu Hamed, Sudan.

Zarroug IM, Hashim K, ElMubark WA, Shumo ZA, Salih KA, ElNojomi NA, Awad HA, Aziz N, Katabarwa M, Hassan HK, Unnasch TR, Mackenzie CD, Richards F, Higazi TB.

Am J Trop Med Hyg. 2016 Nov 2;95(5):1037-1040. Epub 2016 Jun 27.

20.

A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.

Richards FO Jr, Klein RE, de León O, Mendizábal-Cabrera R, Morales AL, Cama V, Crovella CG, Díaz Espinoza CE, Morales Z, Sauerbrey M, Rizzo N.

PLoS Negl Trop Dis. 2016 Jun 24;10(6):e0004777. doi: 10.1371/journal.pntd.0004777. eCollection 2016 Jun.

Supplemental Content

Loading ...
Support Center